Florida Cancer Specialists & Research Institute, Paradigm Health collaborate to expand patient access to clinical trials

Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began

One year after the Centers for Medicare & Medicaid Services made the decision to pay for patient navigation services, data from early adopters show that navigation services are leading to better outcomes, significant cost savings for healthcare systems, and mitigation of health inequities.

First in-office digital hub enhances provider efficiency and communication

PatientPoint, a digital health company, launched an interactive, in-office digital hub that delivers specialty-specific, customizable content and practice tools for clinicians, and allows for streamlined workflows, and enhanced collaboration across care teams.

October 11, 2024

Vol.50 No.38

In Brief

McKesson to acquire controlling stake in Florida Cancer Specialists & Research Institute’s Core Ventures

McKesson Corp. has signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures LLC (Core Ventures).

September 06, 2024

Vol.50 No.33

In Brief

Bradley Monk named medical director of late-phase clinical research at Florida Cancer Specialists

Bradley Monk was named medical director of late-phase clinical research at Florida Cancer Specialists & Research Institute, LLC. Monks plans to leverage his experience and leadership across all tumor types as FCS expands in footprint in late-phase practice changing clinical trials.

October 13, 2023

Vol.49 No.38

Clinical

Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die

Proven curative regimens containing platinum-based drugs—cisplatin and carboplatin—have become largely unavailable because of a nationwide drug shortage. The institutions that have some supplies of cisplatin and carboplatin are setting up algorithms for rationing their dwindling stocks, which usually means giving top priority to patients treated with curative intent and denying standard-of-care treatment to patients who cannot be cured but who can still benefit from these drugs.

May 26, 2023

Vol.49 No.21

By Paul Goldberg

Cleanup continues for cancer clinics after Hurricane Ian tore through Fort Myers

Kristina Mirabeau-Beale was sure that she and her family were well prepared for Hurricane Ian.

October 21, 2022

Vol.48 No.38

By Jacquelyn Cobb

Florida Cancer Specialists & Research Institute, Paradigm Health collaborate to expand patient access to clinical trials

YOU MAY BE INTERESTED IN

Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began

First in-office digital hub enhances provider efficiency and communication

McKesson to acquire controlling stake in Florida Cancer Specialists & Research Institute’s Core Ventures

Bradley Monk named medical director of late-phase clinical research at Florida Cancer Specialists

Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die

Cleanup continues for cancer clinics after Hurricane Ian tore through Fort Myers

Renew today!

Subscriber content

Never miss an issue!

Login

Florida Cancer Specialists & Research Institute, Paradigm Health collaborate to expand patient access to clinical trials

YOU MAY BE INTERESTED IN

Patient navigation benefits health systems, improves careInitial data presented at the White House come a year after CMS payment began

First in-office digital hub enhances provider efficiency and communication

McKesson to acquire controlling stake in Florida Cancer Specialists & Research Institute’s Core Ventures

Bradley Monk named medical director of late-phase clinical research at Florida Cancer Specialists

Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die

Cleanup continues for cancer clinics after Hurricane Ian tore through Fort Myers

Never miss an issue!

Login

Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began